Levodopa
(asked on 2nd July 2014) - View Source
Question to the Department of Health and Social Care:
To ask Her Majesty's Government what advice the Clinical Priorities Advisory Group received about the routine use of Duodopa for advanced Parkinson's disease.
This question was answered on 9th July 2014
We understand that the Clinical Priorities Advisory Group considered evidence on the clinical effectiveness and estimated costs of Duodopa. NHS England plans to publish a commissioning policy statement for Duodopa in due course.